Wired.com reports on some recent moves on the Food and Drug Administration's part to approve clinical trials involving illegal psychedlics and empathogens. Currently, they report, Dr. Charles Grob is using psilocybin to try to treat anxiety in terminal cancer patients; Dr. Francisco Moreno is using the same drug, the most active ingrediant in psychedelic mushrooms, to treat obsessive-compulsive disorder; and the Multidisciplinary Association for Psychedlics Studies is sponsoring MDMA (ecstasy) tests on post-tramautic stress sufferers, all with FDA approval.
Reason on Facebook
Reason on Twitter
Reason on YouTube
Reason RSS
Site comments/questions:
Media Inquiries and Reprint Permissions:
(310) 367-6109
Editorial & Production Offices:
3415 S. Sepulveda Blvd.
Suite 400
Los Angeles, CA 90034
(310) 391-2245